Your Health, We Care
The most common (>20%) adverse reactions are diarrhea, rash, stomatitis, vomiting, decreased appetite, paronychia, nausea, musculoskeletal pain, dry skin, fatigue, cough, pruritus, and decreased weight. The most common (≥2%) Grade 3 or 4 laboratory abnormalities were decreased lymphocytes, increased amylase, increased lipase, decreased potassium, decreased red blood cells, increased creatinine, decreased magnesium and increased alanine aminotransferase.
from FDA，2023.09
Exkivityimproves patient outcomes by inhibiting specific mutant kinases and bloc···【more】
Release date：2024-08-08Recommended：129
Exkivity effectively inhibits the growth and spread of tumor cells by precisely ···【more】
Release date：2024-08-08Recommended：151
Exkivityis an innovative third-representative dermal growth factor receptor (EGF···【more】
Release date：2024-08-08Recommended：114
